Clinical trial
A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in…
NCT00002384 · Gilead Sciences, Industry · Unknown status
Key facts
| NCT number | NCT00002384 |
|---|---|
| Title | A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS |
| Official title | Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS |
| Lead sponsor | Gilead Sciences, Industry |
| Collaborators | Anderson Clinical Research Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Cytomegalovirus Retinitis, HIV Infections |
| Intervention type | Drug |
| Interventions | Cidofovir |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: